IBDEI0NN ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,10643,1,4,0)
;;=4^G31.84
;;^UTILITY(U,$J,358.3,10643,2)
;;=^5003813
;;^UTILITY(U,$J,358.3,10644,0)
;;=F01.51^^42^472^49
;;^UTILITY(U,$J,358.3,10644,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10644,1,3,0)
;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
;;^UTILITY(U,$J,358.3,10644,1,4,0)
;;=4^F01.51
;;^UTILITY(U,$J,358.3,10644,2)
;;=^5003047
;;^UTILITY(U,$J,358.3,10645,0)
;;=F01.50^^42^472^50
;;^UTILITY(U,$J,358.3,10645,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10645,1,3,0)
;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
;;^UTILITY(U,$J,358.3,10645,1,4,0)
;;=4^F01.50
;;^UTILITY(U,$J,358.3,10645,2)
;;=^5003046
;;^UTILITY(U,$J,358.3,10646,0)
;;=G31.84^^42^472^66
;;^UTILITY(U,$J,358.3,10646,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10646,1,3,0)
;;=3^Mild Neurocog D/O d/t VASCULAR DISEASE
;;^UTILITY(U,$J,358.3,10646,1,4,0)
;;=4^G31.84
;;^UTILITY(U,$J,358.3,10646,2)
;;=^5003813
;;^UTILITY(U,$J,358.3,10647,0)
;;=R41.9^^42^472^69
;;^UTILITY(U,$J,358.3,10647,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10647,1,3,0)
;;=3^Neurocognitive Disorder,Unspec
;;^UTILITY(U,$J,358.3,10647,1,4,0)
;;=4^R41.9
;;^UTILITY(U,$J,358.3,10647,2)
;;=^5019449
;;^UTILITY(U,$J,358.3,10648,0)
;;=Z21.^^42^472^22
;;^UTILITY(U,$J,358.3,10648,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10648,1,3,0)
;;=3^HIV Positive/Infection Status
;;^UTILITY(U,$J,358.3,10648,1,4,0)
;;=4^Z21.
;;^UTILITY(U,$J,358.3,10648,2)
;;=^5062777
;;^UTILITY(U,$J,358.3,10649,0)
;;=F06.31^^42^473^1
;;^UTILITY(U,$J,358.3,10649,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10649,1,3,0)
;;=3^Depressive Disorder d/t Another Med Cond w/ Depressive Features
;;^UTILITY(U,$J,358.3,10649,1,4,0)
;;=4^F06.31
;;^UTILITY(U,$J,358.3,10649,2)
;;=^5003057
;;^UTILITY(U,$J,358.3,10650,0)
;;=F06.32^^42^473^2
;;^UTILITY(U,$J,358.3,10650,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10650,1,3,0)
;;=3^Depressive Disorder d/t Another Med Cond w/ Major Depressive-Like Episode
;;^UTILITY(U,$J,358.3,10650,1,4,0)
;;=4^F06.32
;;^UTILITY(U,$J,358.3,10650,2)
;;=^5003058
;;^UTILITY(U,$J,358.3,10651,0)
;;=F32.9^^42^473^17
;;^UTILITY(U,$J,358.3,10651,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10651,1,3,0)
;;=3^MDD,Single Episode,Unspec
;;^UTILITY(U,$J,358.3,10651,1,4,0)
;;=4^F32.9
;;^UTILITY(U,$J,358.3,10651,2)
;;=^5003528
;;^UTILITY(U,$J,358.3,10652,0)
;;=F32.0^^42^473^13
;;^UTILITY(U,$J,358.3,10652,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10652,1,3,0)
;;=3^MDD,Single Episode,Mild
;;^UTILITY(U,$J,358.3,10652,1,4,0)
;;=4^F32.0
;;^UTILITY(U,$J,358.3,10652,2)
;;=^5003521
;;^UTILITY(U,$J,358.3,10653,0)
;;=F32.1^^42^473^14
;;^UTILITY(U,$J,358.3,10653,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10653,1,3,0)
;;=3^MDD,Single Episode,Moderate
;;^UTILITY(U,$J,358.3,10653,1,4,0)
;;=4^F32.1
;;^UTILITY(U,$J,358.3,10653,2)
;;=^5003522
;;^UTILITY(U,$J,358.3,10654,0)
;;=F32.2^^42^473^16
;;^UTILITY(U,$J,358.3,10654,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10654,1,3,0)
;;=3^MDD,Single Episode,Severe w/o Psychotic Feat
;;^UTILITY(U,$J,358.3,10654,1,4,0)
;;=4^F32.2
;;^UTILITY(U,$J,358.3,10654,2)
;;=^5003523
;;^UTILITY(U,$J,358.3,10655,0)
;;=F32.3^^42^473^15
;;^UTILITY(U,$J,358.3,10655,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,10655,1,3,0)
;;=3^MDD,Single Episode,Severe w/ Psychotic Feat
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0NN 3793 printed Sep 23, 2025@19:28:11 Page 2
IBDEI0NN ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,10643,1,4,0)
+2 ;;=4^G31.84
+3 ;;^UTILITY(U,$J,358.3,10643,2)
+4 ;;=^5003813
+5 ;;^UTILITY(U,$J,358.3,10644,0)
+6 ;;=F01.51^^42^472^49
+7 ;;^UTILITY(U,$J,358.3,10644,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,10644,1,3,0)
+10 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
+11 ;;^UTILITY(U,$J,358.3,10644,1,4,0)
+12 ;;=4^F01.51
+13 ;;^UTILITY(U,$J,358.3,10644,2)
+14 ;;=^5003047
+15 ;;^UTILITY(U,$J,358.3,10645,0)
+16 ;;=F01.50^^42^472^50
+17 ;;^UTILITY(U,$J,358.3,10645,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,10645,1,3,0)
+20 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
+21 ;;^UTILITY(U,$J,358.3,10645,1,4,0)
+22 ;;=4^F01.50
+23 ;;^UTILITY(U,$J,358.3,10645,2)
+24 ;;=^5003046
+25 ;;^UTILITY(U,$J,358.3,10646,0)
+26 ;;=G31.84^^42^472^66
+27 ;;^UTILITY(U,$J,358.3,10646,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,10646,1,3,0)
+30 ;;=3^Mild Neurocog D/O d/t VASCULAR DISEASE
+31 ;;^UTILITY(U,$J,358.3,10646,1,4,0)
+32 ;;=4^G31.84
+33 ;;^UTILITY(U,$J,358.3,10646,2)
+34 ;;=^5003813
+35 ;;^UTILITY(U,$J,358.3,10647,0)
+36 ;;=R41.9^^42^472^69
+37 ;;^UTILITY(U,$J,358.3,10647,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,10647,1,3,0)
+40 ;;=3^Neurocognitive Disorder,Unspec
+41 ;;^UTILITY(U,$J,358.3,10647,1,4,0)
+42 ;;=4^R41.9
+43 ;;^UTILITY(U,$J,358.3,10647,2)
+44 ;;=^5019449
+45 ;;^UTILITY(U,$J,358.3,10648,0)
+46 ;;=Z21.^^42^472^22
+47 ;;^UTILITY(U,$J,358.3,10648,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,10648,1,3,0)
+50 ;;=3^HIV Positive/Infection Status
+51 ;;^UTILITY(U,$J,358.3,10648,1,4,0)
+52 ;;=4^Z21.
+53 ;;^UTILITY(U,$J,358.3,10648,2)
+54 ;;=^5062777
+55 ;;^UTILITY(U,$J,358.3,10649,0)
+56 ;;=F06.31^^42^473^1
+57 ;;^UTILITY(U,$J,358.3,10649,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,10649,1,3,0)
+60 ;;=3^Depressive Disorder d/t Another Med Cond w/ Depressive Features
+61 ;;^UTILITY(U,$J,358.3,10649,1,4,0)
+62 ;;=4^F06.31
+63 ;;^UTILITY(U,$J,358.3,10649,2)
+64 ;;=^5003057
+65 ;;^UTILITY(U,$J,358.3,10650,0)
+66 ;;=F06.32^^42^473^2
+67 ;;^UTILITY(U,$J,358.3,10650,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,10650,1,3,0)
+70 ;;=3^Depressive Disorder d/t Another Med Cond w/ Major Depressive-Like Episode
+71 ;;^UTILITY(U,$J,358.3,10650,1,4,0)
+72 ;;=4^F06.32
+73 ;;^UTILITY(U,$J,358.3,10650,2)
+74 ;;=^5003058
+75 ;;^UTILITY(U,$J,358.3,10651,0)
+76 ;;=F32.9^^42^473^17
+77 ;;^UTILITY(U,$J,358.3,10651,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,10651,1,3,0)
+80 ;;=3^MDD,Single Episode,Unspec
+81 ;;^UTILITY(U,$J,358.3,10651,1,4,0)
+82 ;;=4^F32.9
+83 ;;^UTILITY(U,$J,358.3,10651,2)
+84 ;;=^5003528
+85 ;;^UTILITY(U,$J,358.3,10652,0)
+86 ;;=F32.0^^42^473^13
+87 ;;^UTILITY(U,$J,358.3,10652,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,10652,1,3,0)
+90 ;;=3^MDD,Single Episode,Mild
+91 ;;^UTILITY(U,$J,358.3,10652,1,4,0)
+92 ;;=4^F32.0
+93 ;;^UTILITY(U,$J,358.3,10652,2)
+94 ;;=^5003521
+95 ;;^UTILITY(U,$J,358.3,10653,0)
+96 ;;=F32.1^^42^473^14
+97 ;;^UTILITY(U,$J,358.3,10653,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,10653,1,3,0)
+100 ;;=3^MDD,Single Episode,Moderate
+101 ;;^UTILITY(U,$J,358.3,10653,1,4,0)
+102 ;;=4^F32.1
+103 ;;^UTILITY(U,$J,358.3,10653,2)
+104 ;;=^5003522
+105 ;;^UTILITY(U,$J,358.3,10654,0)
+106 ;;=F32.2^^42^473^16
+107 ;;^UTILITY(U,$J,358.3,10654,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,10654,1,3,0)
+110 ;;=3^MDD,Single Episode,Severe w/o Psychotic Feat
+111 ;;^UTILITY(U,$J,358.3,10654,1,4,0)
+112 ;;=4^F32.2
+113 ;;^UTILITY(U,$J,358.3,10654,2)
+114 ;;=^5003523
+115 ;;^UTILITY(U,$J,358.3,10655,0)
+116 ;;=F32.3^^42^473^15
+117 ;;^UTILITY(U,$J,358.3,10655,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,10655,1,3,0)
+120 ;;=3^MDD,Single Episode,Severe w/ Psychotic Feat
